<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/126">
<title>International Journal</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/126</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1277"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1069"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1058"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1038"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1037"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1036"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1031"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1029"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1027"/>
<rdf:li rdf:resource="http://182.160.97.198:8080/xmlui/handle/123456789/1026"/>
</rdf:Seq>
</items>
<dc:date>2026-04-29T08:28:23Z</dc:date>
</channel>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1277">
<title>Co2 emission, power consumption and economic growth in Bangladesh: an ARDL bound testing approach</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1277</link>
<description>Co2 emission, power consumption and economic growth in Bangladesh: an ARDL bound testing approach
Wahid, A.N.M.; Hossain, Anwar; Mahmud, Kazi Tanvir; Alom, Khairul
This paper focuses on the empirical relationship between economic growth, co2 emission, power consumption, fossil fuel energy consumption and financial development of Bangladesh using data of 1985-2013. Findings indicate that a significant relationship exists between economic growth and power consumption, economic growth and fossil fuel energy consumption in the long run. The long run relationship between co2 emission and economic growth as well as financial development is insignificant. Whereas, Granger causality shows that bidirectional association exists among economic growth and power consumption, financial development and economic growth, fossil fuel energy consumption and economic growth in the short run. However, unidirectional casualty has been found among power consumption to financial development, co2 emission to power consumption, fossil fuel energy consumption to financial development, co2 emission to financial development and co2 emission to fossil fuel energy consumption. Error correction mechanism confirms that except power consumption all the explanatory variables quick return to equilibrium in the short run.
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1069">
<title>Self-microemulsifying: a new approach of lipid based drug delivery systems</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1069</link>
<description>Self-microemulsifying: a new approach of lipid based drug delivery systems
Hasan, Md. Mehdi; Rahman, Md. Mizanur; Hasan, Mahbub; Islam, S.M. Nazrul; Hasan, Masum Al; Rashid, Harun Ar
Solubility is one of the key factor in drug formulation in order to ensure better bioavailability. As 40% of new drugs are poorly soluble, it has become a matter of concern and challenge for the formulation scientists with regard to solubility and bioavailability. Though formulation approaches like solid dispersions, complexation, pH modification exist, but there are areas of further research and development for better approaches. Lipid-based drug delivery systems (LBDDS) are one of the emerging technologies designed to address such challenges in recent time. These systems have shown great promise which can lead to increased solubilization and absorption, resulting in enhanced bioavailability. This review provides a comprehensive understandings of Lipid-based drug delivery systems especially for oral delivery, from both physicochemical and biopharmaceutical perspectives. This review also focuses on advanced techniques and processes, along with a brief discussion of various lipid excipients and their characterization.
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1058">
<title>A key approach on dissolution of pharmaceutical  dosage forms</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1058</link>
<description>A key approach on dissolution of pharmaceutical  dosage forms
Hasan, Md.  Mehdi; Rahman, Md.  Mizanur; Islam, Md  Rakibul; Hasan, Hasanuzzaman; Hasan, Md Mehedi; Rashid, Harun Ar
Dissolution  testing  is  a  critical  methodology  which  is  widely  utilized  in  the  development  of  a  new pharmaceutical product. The test, in its simplest form, consists of placing the formulation in a dissolution apparatus containing suitable dissolution medium, allowing it to dissolve over a specified period of time and then assaying the resultant solution using appropriate analytical method to determine the amount of drug.  Dissolution tests are relevant for an array of investigations like drug degradation profiles, stability and  shelf  life  studies,  physical  and  mechanical  testing  of  dosage  forms,  incoming  QC  testing  on  raw materials  etc.  The  present  review  outlines  the  recent  findings  on  various  dissolution apparatuses,  their modifications,  methods  for  degassing  of  media  like  Helium  sparging,  Heating  and  filtering,  Vacuum degassing,  sonication  and  dissolution  testing  of  various  dosage  forms  like  Immediate  Release  (IR) Dosage forms, Delayed Release Dosage Forms, Extended Release Dosage Forms, Transdermal Delivery Systems, Powders, Chewable Tablets,  Buccal Tablets, Chewing Gums, Soft Gelatin Capsule, Aerosols, Suppositories  and  other  Semisolids.  This  article  presents,  a  short  review  on  guidelines  for  dissolution profile testing, particularly focusing on the recommendations regarding statistical methods for assessing profile  similarly.  In  this  context,  the  guidelines  on  in  vitro/in  vivo  correlations  and  on  granting  bio waivers  are  outlined  briefly.  The  goal  of  this  article  is  to  give  a  survey  of  the  current  guidelines, including a description and discussion of the recommended methods for data analysis
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1038">
<title>Development and validation of method for  determination of esomeprazole and naproxen from  cobination product by hplc</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1038</link>
<description>Development and validation of method for  determination of esomeprazole and naproxen from  cobination product by hplc
Bhuyian, Md. Habib Ullah; Tareque, Md. Isha; Islam, A.F.M Ariful; Rashid, Md. Harun Ar
A simple selective and rapid reversed phase high performance liquid chromatographic (RPHPLC) method for the analysis  Esomeprazole  and  Naproxen  has been developed and validated. The separation was achieved from HPLC Column (Cogent, C18 250mm x 4.6  mm, 5 µm) with a mobile phase consisting (Buffer: Acetonitrile: Methanol = 50:40:10, add 0.1% v/v Triethylamine in above mixture and finally adjust with glacial acetic acid to a pH 7.0) flow rate 1.0 ml/min with UV detection at 303 nm. The method was specific and it was observed that no interference with diluents.  Proposed  method  is  accurate  with  (99.87%-100.08%)  recovery  for  Naproxen  and  (99.44%-99.87%) recovery for Esomeprazole.  The proposed method was accurate, and precise for the quantification of Esomeprazole and  Naproxen  in  the  tablet.  The  proposed  method  can  also  be  used  for  routine  analysis  in  quality  control.  The method  was  validated  for  the  parameters  like  selectivity,  sensitivity,  precision,  intermediate  precision,  accuracy, linearity,  recovery  &amp;  stability .  This  RP  -HPLC  method  is  suitable  for  determining  the  concentration  of Esomeprazole and  Naproxen in  tablet and it can applied for routine analysis for determination of the  Esomeprazole and Naproxen from dosage form.
</description>
<dc:date>2015-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1037">
<title>Screening of antidiarrhoeal  activity of three reputed medicinal plants of Bangladesh</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1037</link>
<description>Screening of antidiarrhoeal  activity of three reputed medicinal plants of Bangladesh
Hossain, Mohammad Taleb; Mamun, Abdullah Al; Asadujjaman, Md.; Rahman, Md. Habibur; Morshid, Gazi Monjur
Anonna squamosa Linn. (Fam: Anonnaceae), Calotropis procera R. Br. (Fam: Asclepiadaceae), and Piper betel  Linn.  (Fam:  Piperaceae)  leaves  have  been  used  in  conventional  therapies  for  various  disease conditions, including diarrhea. So, the present study was aimed to evaluate the antidiarrhoeal activity of ethanol extracts of the leaves of the above mentioned plants. Antidiarrhoeal activity was evaluated against &#13;
an  experimental  model  of  castor  oil-induced  diarrhea  in  mice.  In  antidiarrheal  activity  test,  oral administration of the mentioned ethanol extracts (250 and 500 mg/kg) showed significant (P&lt;0.01) and dose-dependent  inhibition.  Onset  of  diarrhea  after  administration  of  250  mg/kg  and  500  mg/kg  of  A. squamosa  were 88.8 mins and 102.6 mins, of C. procera  were 83.4 mins and 118.2 mins, and of P. betelwere 81.0 mins and 115.8 mins, respectively as compared to 70.2 mins and 131.4 minsdemonstrated by &#13;
control (1% Tween-80 in saline) and positive control (Loperamide), respectively. The result indicates  the &#13;
presence of some active principles in the plant extracts which might have a correlation with the revealed &#13;
anti-diarrhoeal activities of these plants. The results also justify their traditional uses in the treatment of &#13;
diarrhea
</description>
<dc:date>2015-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1036">
<title>Compensatory strategy on ocular drug delivery system</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1036</link>
<description>Compensatory strategy on ocular drug delivery system
Hasan, Md. Mehdi; Moniruzzaman, Md.; Anee, Mubashwera; Rahaman, Md.Saydur; Rabbani, Golam; Banik, Kallol; Rashid, Harun Ar
Ocular anatomy and physiology is very unique which is why it creates a challenge in developing drugs given by ocular routes. The Eye  has  several layers of tissues in it. This route is extremely effective due to its rapid onset of action and small dose requirement. Transcorneal penetration is the route of absorption ofdrug.Several different dosage forms are being developed e.g nanoparticles, liposomes, nanomicelles and microemulsion to overcome difficul ties in drug delivery by this route. This review focused on ocular drug delivery has become the standard in modern pharmaceutical design and several possible routes of drug delivery into the ocular tissues
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1031">
<title>Mixture design experiment on dissolution of pioglitazone hcl solid dispersion as affected by hydrophilic polymers interaction</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1031</link>
<description>Mixture design experiment on dissolution of pioglitazone hcl solid dispersion as affected by hydrophilic polymers interaction
Rashid, Harun Ar; Faisal, Khandokar Sadique; Bhyian, Md. Habib Ullah; Alam, Md. Jahangir; Hasan, Md.Mehdi
Methods available to improve dissolution include salt formation, micronization and addition of solvent or surface active agents. The development of solid dispersions as a practically viable method to enhance bioavailability of poorly  water soluble drugs overcame the limitations of those previous approaches. No studies, to date, have systematically examined the effect of different hydrophilic polymer on the dissolution of poorly water soluble drug. In this study, interaction effect of propyl  methyl  cellulose  cp15  (HPMC  cp15),  polyethylene  glycol  6000  (PEG  6000),  povidone  30  (PVP  K30), eudragit EPO, polaxamer 407 on dissolution of pioglitazone HCl  solid dispersion  were  investigated by a  mixture design experiment. Blends of HPMC, PEG 6000, PVP K30, eudragit and polaxamer 407 were prepared according to an augmented simplex-centroid  mixture  design  (10  points)  and  the  drug  polymer  ratio  was  1:3  in  the  solid  dispersion  formulation.  An appropriate mathematical model was fitted to express  the response. The synergistic effect of HPMC : PG : POLOXMER, had shown to be much stronger in quaternary blends. In addition, Eudragit showed an tagonistic effect (p&lt;.05). The contour plot reveled the effects of  the tertiary bends on  the dissolution of pioglitazone. Tertiary blend of HPMC, PVP and  PEG demonstrated a synergistic effect on the dissolution, at higher proportion of PEG. This study suggested that a mixture design approach could serve as a valuable tool in better elucidating and predicting the interaction effects beyond the conventional polymers blends.
</description>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1029">
<title>Pharmaceutical  pre formulation  for  product development and analytical techniques use in new  dosage form</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1029</link>
<description>Pharmaceutical  pre formulation  for  product development and analytical techniques use in new  dosage form
Hasan, Md. Mehdi; Habib, Sabbir Al; Islam, Mumu Mishouri; Islam, Md. Mohshin; Karim, Md. Salimul; Banik, kallol; Rashid, Harun Ar
Fundamentals  to  preformulation  studies  are  analytical  techniques.  Evaluation  of  the  quality  of  materials, precursors  of  products  or  final  product  is  not  possible  without  them.  Measuring  pharmacological  and  biological response in  the clinical and preclinical stages are also not  possible  without them.  Analytical techniques should be selected based on several categories such as specificity, accuracy, precision, sensitivity, and speed of a test must be verified  for  selection  of  the  method.  Several  analytical  techniques  like  Spectroscopic,  Chromatographic,  Thermal methods  and  some  specific  detection  methods  like  Capillary  electrophoresis  are  very  convenient  method  for generating preformulation data. The intrinsic chemical data and physical properties of every drug are distinctively considered  before development of pharmaceutical formulation. This property of drug act as the basic structure that is responsible for the binding of drug with other pharmaceutical ingredients. Several research scientist carries out these preformulation  studies  and  they  are  again  reviewed  later.  When  a  preformulation  study  is  executed  on  a  newly synthesized  compounds  or  extracted  compound,  several  crucial  information  such  as  the  degradation  process,  any adverse conditions relevant to the drug, bioavailability, pharmacokinetics and formulation of similar compound and toxicity can be obtained. Preformulation studies strengthen the scientific foundation of the steerage, give restrictive relief  and  conserve  resources  within  the  drug  development  and  analysis  method,  improve   public  safety  standards, enhance  product  quality  within  the  fabrication  of  indefinite  quantity  type.  Objective  of  preformulation  study  is  to develop  the  exquisite,  stable,  effective  and  safe  indefinite  quantity  kind  by  establishing  kinetic  rate  profile, compatibility  with  the  opposite  ingredients  and  establish  physicochemical  parameter  of  new  drug  substances. Polymorphic substances who have both amorphous and crystal forms shows totally different chemical, physical and &#13;
therapeutic  description  of  the  drug  molecule.  The  main  purpose  of  this  review  article  focuses  on  the  various preformulation factors which distinctly impacts the development of new dosage form like drug solubility, partition coefficient, dissolution rate, polymorphic forms and stability. The present article is framed with the target to produce an in-depth insight the appliance of Analytical Techniques in Preformulation Study
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1027">
<title>Comparative study of anti-hyperlipidemic effect of  zingiber officinale,momordica charantia, trigonella foenum-graecum, dillenia indica and tamarindus indica.</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1027</link>
<description>Comparative study of anti-hyperlipidemic effect of  zingiber officinale,momordica charantia, trigonella foenum-graecum, dillenia indica and tamarindus indica.
Chowdhury, Asif Alam; Sukul, Abhijit; khan, Imdadul huque; Mamun, Yasir; Chowdhury, Imran; Raihan, Sheikh Zahir
This  dissertation  aimed  to  compare  the  antihyperlipidemic  effects  of &#13;
methanolic  extract  of  Zingiber  officinale,  Momordica  charantia, &#13;
Trigonella foenum-graecum, Dillenia indica and Tamarindus indica in &#13;
hyperlipidemic animal models. Atorvastatin was used as standard drug. &#13;
The  crude  extract  (100  mg/kg)  of  these  significantly  prevented  the &#13;
increase  in  low  density  lipoprotein  (LDL),  total  cholesterol  (TC), &#13;
triglyceride  (TG)  and  significantly  increased  the  HDL  level  in  blood &#13;
serum.  The  reduction  in  serum  level  of  above  parameters  was &#13;
compared  with  atorvastatin  and  then  within  themselves.  Among  the &#13;
five samples, Zingiber officinale extract showed significant Cholesterol &#13;
reduction property (p&lt;0.001) compared to other extracts. Momordica&#13;
charantia  &amp;  Dilenia  indica  (p&lt;0.001)  significantly  increased  the  blood  HDL  cholesterol level.  Zingiber  officinale,  Dilenia  indica  &amp;  Tamarindus  indica  significantly  reduced  LDL level in blood (p&lt;0.001).  Momordica  charantia  &amp;  Trigonella  foenum-graecum  significantly reduced TG level  (p&lt;0.001) in blood serum of rats. So,  the above results confirmed that all extracts are potent against hyperlipidemia
</description>
<dc:date>2015-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://182.160.97.198:8080/xmlui/handle/123456789/1026">
<title>Granulation techniques &amp; its updated modules</title>
<link>http://182.160.97.198:8080/xmlui/handle/123456789/1026</link>
<description>Granulation techniques &amp; its updated modules
Jannat, Esratun; Arif, Abdullah Al; Hasan, Md. Mehdi; Zarziz, Abdullah Bin; Rashid, Harun Ar
Granulation is the process in which primary powder particles are made to adhere to form larger multiparticle  entities  called  granules.  Granulation  is  required  to  avoid  segregation,  enhance  the  flow  of powder,  to  produce  uniform  mixture,  to  produce  dust  free  formulation,  to  eliminate  poor  content uniformity and to improve compaction characteristics of mix. Granulation method is mainly divided into two  types:  wet  granulation  and  dry  granulation.  Like  any  other  scientific  field,  pharmaceutical granulation  technology  also  continues  to  change,  and  arrival  of novel  and  innovative  technologies  are inevitable.  This  review  focuses  on  the  recent  progress  in  the  granulation  techniques  and  technologies such  as  pneumatic  dry  granulation,  reverse  wet  granulation,  steam  granulation,  moisture-activated  dry granulation, thermal  adhesion  granulation,  freeze  granulation, and  foamed  binder  or  foam  granulation. This review gives an overview ofthese with a short descriptionabout each development along with its significance and limitations. During the formulation development, each drug substance poses a unique challenge  that  must  be  taken  into  consideration  at  the  process selection  stage  by  the  formulation development scientists.
</description>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
